Patents by Inventor Korea Research Institute of Chemical Technology

Korea Research Institute of Chemical Technology has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130217881
    Abstract: The present invention relates to a compound represented by formula 1 in the present specification or a pharmaceutically acceptable thereof, which inhibits an apoptosis mechanism of auditory hair cells for various ototoxicities leading to deafness, and protects the auditory organ and hearing, a method for preparation thereof, and a composition containing the same.
    Type: Application
    Filed: December 11, 2012
    Publication date: August 22, 2013
    Applicants: Korea Research Institute of Chemical Technology, Ajou University Industry-Academic Cooperation Foundation
    Inventors: Ajou University Industry-Academic Cooperation Foundation, Korea Research Institute of Chemical Technology
  • Publication number: 20130123297
    Abstract: A pharmaceutical composition comprising a phenyltetrazole derivative of formula (I) or a pharmaceutical acceptable salt thereof is effective in preventing or treating osteoporosis, obesity, diabetes, or hyperlipidemia, by regulating protein TAZ. wherein, A is ethyl or n-butyl; R1 is methyl, —CH2OH, —CO2CH3, —CH2F, —CH(OCH3)2, —CH2OC(?O)CH3, styryl or —CH2OCH2SCH3; R2 is H, Br, —CO2CH3, phenyl, pyridin-2-yl, pyridin-3-yl, or styryl; R3 is H or methyl; X is CH or N; and P is H or —CH(CH3)OCH2CH3.
    Type: Application
    Filed: January 4, 2013
    Publication date: May 16, 2013
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventor: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
  • Publication number: 20130084329
    Abstract: The present invention relates to a composition for external application for improving a skin disease (e.g. psoriasis). The composition contains adenosylcobalamin (coenzyme B12), optionally in admixture with other cobalamins. The composition can be present in the form of liposomal preparations, which are made of a phospholipid and cholesterol.
    Type: Application
    Filed: November 16, 2012
    Publication date: April 4, 2013
    Applicants: HANALL BIOPHARMA CO., LTD., KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Korea Research Institute of Chemical Technology, HANALL BIOPHARMA CO., LTD.
  • Publication number: 20130078256
    Abstract: The invention is related to compounds of Formula (I): or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
    Type: Application
    Filed: November 20, 2012
    Publication date: March 28, 2013
    Applicant: Korea Research Institute of Chemical Technology
    Inventor: Korea Research Institute of Chemical Technology
  • Publication number: 20130053390
    Abstract: The present invention relates to novel quinoxaline-piperazine compounds, 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives and their pharmaceutically acceptable salts, a process for their preparation thereof, and compositions containing such compounds. Therapeutic methods for the treatment of hyperproliferative disorders, including cancers, by administering quinoxaline-piperazine compounds are also included.
    Type: Application
    Filed: October 26, 2012
    Publication date: February 28, 2013
    Applicants: Korea Research Institute of Chemical Technology
    Inventors: Korea Research Institute of Chemical Technology, REXAHN PHARMACEUTICALS, INC.